Peptide Nucleic Acid Origami for Cancer Diagnostics

Liquid biopsy offers a minimally invasive approach to cancer detection and monitoring, but the analysis of rare, fragmented tumor-derived nucleic acids remains challenging because of their low abundance and interference from wild-type sequences. Peptide nucleic acids (PNAs), with their high-affinity hybridization, nuclease resistance, and single-base mismatch discrimination, provide a promising molecular recognition strategy for cancer diagnostics. This review critically examines PNA-based biosensors, PNA-containing nanostructures and emerging PNA-origami-inspired architectures for precision oncology. Unlike recent reviews that discuss only PNA chemistry, utilized in biosensing the individual biomarkers and DNA-origami technologies, this review uniquely focuses on PNA-origami nanoarchitectures for cancer diagnostics in nanoscale-level detection. It critically examines how the chemical modification, programmable nanoscale arrangement, and spatial arrangement of probes and reporters may enable multiplexed detection of cancer-associated mutations, DNA methylation signatures, gene-fusion junctions and circulating microRNAs in liquid-biopsy samples. Optical, plasmonic, colorimetric, electrochemical, and nanopore-based detection strategies are discussed alongside established PNA-clamping and biosensing approaches. Emphasis is placed on analytical performance, structural characterization, matrix compatibility, reproducibility, scalability, and benchmarking against digital PCR, next-generation sequencing, and CRISPR-based diagnostics. Key translation barriers include scalable production, reproducible assembly, matrix compatibility, analytical benchmarking and validation using patient-derived specimens. Currently, PNA origami should be considered a preclinical, origami-inspired design framework for spatially organized and multiplexed cancer biomarker detection, rather than a clinically implemented diagnostic technology.

Authors

Institutions

Publication Details

Journal
Biosensors
Published
2026-11-13
DOI
https://doi.org/10.3390/bios16110652
Primary Topic
Advanced biosensing and bioanalysis techniques
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Peptide Nucleic Acid Origami for Cancer Diagnostics

Murali Mohan Yallapu, Everardo Cobos, Satheesh Natarajan, Subhash Chandra Chauhan
2 links
Biosensors
Advanced biosensing and bioanalysis techniques
article

Peptide Nucleic Acid Origami for Cancer Diagnostics

Murali Mohan Yallapu, Everardo Cobos, Satheesh Natarajan, Subhash Chandra Chauhan
article en

Abstract

Liquid biopsy offers a minimally invasive approach to cancer detection and monitoring, but the analysis of rare, fragmented tumor-derived nucleic acids remains challenging because of their low abundance and interference from wild-type sequences. Peptide nucleic acids (PNAs), with their high-affinity hybridization, nuclease resistance, and single-base mismatch discrimination, provide a promising molecular recognition strategy for cancer diagnostics. This review critically examines PNA-based biosensors, PNA-containing nanostructures and emerging PNA-origami-inspired architectures for precision oncology. Unlike recent reviews that discuss only PNA chemistry, utilized in biosensing the individual biomarkers and DNA-origami technologies, this review uniquely focuses on PNA-origami nanoarchitectures for cancer diagnostics in nanoscale-level detection. It critically examines how the chemical modification, programmable nanoscale arrangement, and spatial arrangement of probes and reporters may enable multiplexed detection of cancer-associated mutations, DNA methylation signatures, gene-fusion junctions and circulating microRNAs in liquid-biopsy samples. Optical, plasmonic, colorimetric, electrochemical, and nanopore-based detection strategies are discussed alongside established PNA-clamping and biosensing approaches. Emphasis is placed on analytical performance, structural characterization, matrix compatibility, reproducibility, scalability, and benchmarking against digital PCR, next-generation sequencing, and CRISPR-based diagnostics. Key translation barriers include scalable production, reproducible assembly, matrix compatibility, analytical benchmarking and validation using patient-derived specimens. Currently, PNA origami should be considered a preclinical, origami-inspired design framework for spatially organized and multiplexed cancer biomarker detection, rather than a clinically implemented diagnostic technology.

BiosensorsVol. 16(11)
The University of Texas Rio Grande Valley (US)
Cancer Prevention and Research Institute of Texas, National Institutes of Health, National Institute of General Medical Sciences
Good health and well-being
Advanced biosensing and bioanalysis techniques
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon